Treatment of resistant pain in hypertrophic pulmonary arthropathy with ketorolac.
Pain associated with hypertrophic pulmonary osteoarthropathy (HPOA) may be extremely disabling and resistant to treatment. The successful use of ketorolac, a new non-steroidal anti-inflammatory drug, given by subcutaneous infusion is reported in two patients with uncontrolled pain caused by HPOA.
Blackwell
N
N
Mount Vernon Hospital, Northwood, Middlesex.
Bangham
L
L
Hughes
M
M
Melzack
D
D
Trotman
I
I
D000279:Administration, Cutaneous; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000150:complications; D004351:Drug Resistance; D006801:Humans; D020910:Ketorolac; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D014046:Tolmetin; D020910:Ketorolac